4th Antivirals Congress 2016

Antiviral research

antivirals-research

A journal for research on the prevention and treatment of viral diseases

Antiviral Research Editorial Team

Mike Bray (Editor-in-Chief), Bethesda, Maryland, USA; Editors: Dale Barnard, Logan, Utah, USA; David Durantel, Lyon, France; José Esté, Barcelona, Spain; Jennifer McKimm-Breschkin, Parkville, Victoria, Australia; Johan Neyts, Leuven, Belgium; Mark Prichard, Birmingham, Alabama, USA; Subhash Vasudevan, Singapore. Meet the complete Editorial Board on the journal homepage.

Antiviral Research is an official publication of the International Society for Antiviral Research. It publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals.

Its scope encompasses:

  • Antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action;
  • New or improved vaccines against viral infections of humans and animals;
  • Assessments of drug and vaccine safety;
  • Evolution of drug- or vaccine-resistant viruses and the development of effective countermeasures;
  • Identification and validation of new drug targets;
  • Laboratory animal models of viral diseases;
  • Pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses.

Highlighted Articles
Editor-in-Chief, Mike Bray selects and highlights an outstanding article from Antiviral Research every month and shares it for free with researchers. Check out the latest Highlighted Articles on the journal homepage.

Antiviral Research Symposia
We invite you to check out our Symposia, which share the latest research on below topics, with free access to the latest papers.

Chikungunya
The symposium reviews the pathogenesis, clinical features, epidemiology and treatment of chikungunya, focusing on its recent spread to the New World, and discusses a variety of responses that might help limit the impact of the disease. Read more.

Flavivirus Drug Discovery
The articles in this symposium review current efforts to develop antiviral therapies for dengue and other acute flaviviral infections, which now afflicts many millions of people each year in tropical regions, causing large numbers of deaths in children. Guest editors are Shee-Mei Lok and Pei-Yong Shi. Read more.

Hepatitis B
This joint project of Antiviral Research with the Hepatitis B Foundation offers you the latest research on the history, pathophysiology and current management of hepatitis B. It also describes a wave of newly identified drug targets, investigational compounds and experimental strategies that are now under clinical evaluation or in preclinical development. Read more.

Hepatitis C
This symposium marks the 25th anniversary of the discovery of the hepatitis C virus and includes research on epidemiology, clinical syndrome, pathogenesis, vaccines and therapies. Guest Editors are Geneviève Inchauspé, Johan Neyts, Charlie Rice and David Thomas. Read more.

From SARS to MERS
This symposium presents research on highly pathogenic human coronaviruses. Guest Editors are Rolf Hilgenfeld and Malik Peiris. Read more.